Lesley Calhoun, Treasurer

Lesley Ann Calhoun currently serves as EVP, Chief Financial Officer at Aligos Therapeutics. She formerly served as the Vice President, Finance and Chief Accounting Officer of Global Blood Therapeutics, Inc. since August 2016. Ms. Calhoun previously served as vice president, finance at Hyperion Therapeutics, Inc., a commercial pharmaceutical company, from January 2013 to September 2015, which was acquired by Horizon Pharma plc, a biopharmaceutical company, in May 2015. Prior to Horizon Pharma, Ms. Calhoun served as senior director of finance and corporate controller at Theravance, Inc., a biopharmaceutical company, from August 2005 to January 2013. Prior to Theravance, Ms. Calhoun held various senior finance positions of increasing responsibility where she oversaw all aspects of finance, accounting and treasury operations for U.S. and multinational, publicly-traded and pre-IPO stage technology companies and in the biopharmaceutical industry. Earlier in her career, Ms. Calhoun was a member of the audit practice of Deloitte & Touche LLP from 1989 to 2001. Ms. Calhoun holds a B.S. in business administration with a concentration in accounting from San Francisco State University and is a Certified Public Accountant (inactive).